Chronic critical illness: The price of survival

European Journal of Clinical Investigation

Volumn 45, Issue 12, 2015, Pages 1341-1349

  Marchioni, Alessandro ^a   Fantini, Riccardo ^a   Antenora, Federico ^a   Clini, Enrico ^a   Fabbri, Leonardo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chronic critical illness; Mechanical ventilation; Systemic inflammation; Wasting syndrome

Indexed keywords

BIOETHICS; BRAIN DYSFUNCTION; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); CRITICAL ILLNESS; ENDOCRINE DISEASE; HUMAN; INFLAMMATION; MALNUTRITION; MUSCLE WEAKNESS; NONHUMAN; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; SYSTEMIC DISEASE; BRAIN DISEASE; CONVALESCENCE; ENDOCRINE SYSTEM DISEASES; MORTALITY; PHYSIOLOGY;

BRAIN DISEASES; CHRONIC DISEASE; CRITICAL ILLNESS; ENDOCRINE SYSTEM DISEASES; HUMANS; INFLAMMATION; MALNUTRITION; MUSCLE WEAKNESS; PROGNOSIS; RECOVERY OF FUNCTION;

EID: 84983151033     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12547     Document Type: Review

References (82)

1. Rosengart MR. Critical care medicine: landmarks and legends. Surg Clin North Am 2006;86:1305-21.
2. Berthelsen PG, Cronqvist M. The first intensive care unit in the world: Copenhagen 1953. Acta Anaesthesiol Scand 2003;47:1190-5.
3. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37-43.
4. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2071-94.
5. Girard K, Raffin TA. The chronically critically ill: to save or let die? Respir Care 1985;30:339-47.
6. Carson SS. Definitions and epidemiology of the chronically critically ill. Respir Care 2012;57:848-56; discussion 56-8.
7. MacIntyre NR, Epstein SK, Carson S, Scheinhorn D, Christopher K, Muldoon S. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference. Chest 2005;128:3937-54.
8. Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med 2010;182:446-54.
9. Engoren M, Arslanian-Engoren C, Fenn-Buderer N. Hospital and long-term outcome after tracheostomy for respiratory failure. Chest 2004;125:220-7.
10. Carson SS, Garrett J, Hanson LC, Lanier J, Govert J, Brake MC et al. A prognostic model for one-year mortality in patients requiring prolonged mechanical ventilation. Crit Care Med 2008;36:2061-9.
11. Scheinhorn DJ, Hassenpflug MS, Votto JJ, Chao DC, Epstein SK, Doig GS et al. Post-ICU mechanical ventilation at 23 long-term care hospitals: a multicenter outcomes study. Chest 2007;131:85-93.
12. Cox CE, Carson SS, Lindquist JH, Olsen MK, Govert JA, Chelluri L; Quality of Life After Mechanical Ventilation in the Aged (QOL-MV) Investigators. Differences in one-year health outcomes and resource utilization by definition of prolonged mechanical ventilation: a prospective cohort study. Crit Care 2007;11:R9.
13. Stoller JK, Xu M, Mascha E, Rice R. Long-term outcomes for patients discharged from a long-term hospital-based weaning unit. Chest 2003;124:1892-9.
14. Cox CE. Persistent systemic inflammation in chronic critical illness. Respir Care 2012;57:859-64; discussion 64-6.
15. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.
16. Kale SS, Yende S. Effects of aging on inflammation and hemostasis through the continuum of critical illness. Aging Dis 2011;2:501-11.
17. Fullerton JN, O'Brien AJ, Gilroy DW. Pathways mediating resolution of inflammation: when enough is too much. J Pathol 2013;231:8-20.
18. Nathan C, Ding A. Nonresolving inflammation. Cell 2010;140:871-82.
19. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-8.
20. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013;13:862-74.
21. Boonen E, Van den Berghe G. Endocrine responses to critical illness: novel insights and therapeutic implications. J Clin Endocrinol Metab 2014;99:1569-82.
22. Prigent H, Maxime V, Annane D. Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 2004;8:243-52.
23. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-93.
24. Beishuizen A, Thijs LG. The immunoneuroendocrine axis in critical illness: beneficial adaptation or neuroendocrine exhaustion? Curr Opin Crit Care 2004;10:461-7.
25. Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013;368:1477-88.
26. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373:1798-807.
27. Krinsley JS. Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!. Crit Care 2013;17:131.
28. Schulman RC, Mechanick J. Metabolic and nutrition support in the chronic critical illness syndrome. Respir Care 2012;57:958-77.
29. Chang HR, Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Enteral Nutr 1998;22:156-66.
30. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004;104:1258-64.
31. Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med 2009;361:1088-97.
32. Deane A, Chapman MJ, Fraser RJ, Horowitz M. Bench-to-bedside review:the gut as an endocrine organ in the critically ill. Crit Care 2010;14:228.
33. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes 2009;58:641-51.
34. Hadjiyanni I, Siminovitch KA, Danska JS, Drucker DJ. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cell. Diabetologia 2010;53:730-40.
35. Chatila TA. Regulatory T cells: key players in tolerance and autoimmunity. Endocrinol Metab Clin North Am 2009;38:265-72.
36. Bakiner O, Bozkirli E, Giray S, Arlier Z, Kozanoglu I, Sezgin N et al. Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study. Crit Care 2013;17:R123.
37. Girard DT. Brain dysfunction in patients with chronic critical illness. Resp Care 2012;57:947-55.
38. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE jr, Inouye SK et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-62.
39. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009;180:1092-7.
40. Shehabi Y, Riker RR, Bokesch PM, Wisemandle W, Shintani A, Ely EW. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010;38:2311-8.
41. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010;38:1513-20.
42. Nelson JE, Tandon N, Mercado AF, Camhi SL, Ely EW, Morrison RS. Brain dysfunction:another burden for the chronically critically ill. Arch Intern Med 2006;166:1993-9.
43. Scheinhorn DJ, Hassenpflug MS, Votto JJ, Chao DC, Epstein SK, Doig GS et al. Ventilator-dependent survivors of catastrophic illness transferred to 23 long-term care hospitals for weaning from prolonged mechanical ventilation. Chest 2007;131:76-84.
44. Ceriana P, Fanfulla F, Mazzacane F, Santoro C, Nava S. Delirium in patients admitted to a step-down unit: analysis of incidence and risk factors. J Crit Care 2010;25:136-43.
45. Jubran A, Lawm G, Kelly J, Duffner LA, Grungor G, Collins EG et al. Depressive disorders during weaning from prolonged mechanical ventilation. Intensive Care Med 2010;36:828-35.
46. Unroe M, Kahan JM, Carson SS, Govert JA, Martinu T, Sathy SJ et al. One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. Ann Intern Med 2010;152:167-75.
47. Nelson JE, Mercado AF, Camhi SL, Tandon N, Wallenstein S, August GI et al. Communication about chronic critical illness. Arch Intern Med 2007;167:2509-15.
48. Hope AA, Morrison RS, Du Q, Wallenstein S, Nelson JE. Risk factors for long-tem brian dysfunction after chronic critical illness. Ann Am Thorac Soc 2013;10:315-23.
49. Trzepacz PT. Update on neuropathogenesis of delirium. Dement Geriatr Cogn Disord 1999;10:330-4.
50. Girard TD, Pandharipande PP, Ely EW. Delirium in intensive care unit. Crit Care 2008;12(Suppl 3):S3.
51. Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci 1999;96:461-6.
52. Van Der Mast RC. Pathophysiology of delirium. J Geriatr Psychiatry Neurol 1998;11:138-45.
53. Hughes CG, Morandi A, Girard TD, Riedel B, Thompson JL, Shintani AK et al. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology 2013;118:631-9.
54. Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotrasmitter synthesis. Pharmacol Rev 1980;32:315-35.
55. Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008;65:34-41.
56. Schweickert WD, Hall J. ICU-acquired weakness. Chest 2007;131:1541-9.
57. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013;187:238-46.
58. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol 2003;106:75-82.
59. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013;45:2121-9.
60. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013;280:4294-314.
61. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M et al. Autophagy is required to maintain muscle mass. Cell Metab 2009;10:507-15.
62. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P et al. Critical illness myopathy and neuropathy. Lancet 1996;347:1579-82.
63. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-92.
64. Van den Berghe G, Baxter RC, Weekers F, et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002;56:655-69.
65. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-61.
66. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373:1874-82.
67. Winkelman C, Higgins PA, Chen YJ, Levine AD. Cytokines in chronically critically ill patients after activity and rest. Biol Res Nurs 2007;8:261-71.
68. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
69. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
70. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
71. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008;358:1327-35.
72. Jaber S, Petrof BJ, Jung B, et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 2011;183:364-71.
73. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371:126-34.
74. Kattelmann KK, Hise M, Russell M, Charney P, Stokes M, Compher C. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients. J Am Diet Assoc 2006;106:1226-41.
75. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009;33:277-316.
76. Casaer MP, Ziegler TR. Nutritional support in critical illness and recovery. Lancet Diabetes Endocrinol 2015;3:734-745.
77. Rubinson L, Diette GB, Song X, Brower RG, Krishnan JA. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med 2004;32:350-7.
78. Barr J, Hecht M, Flavin KE, Khorana A, Gould MK. Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest 2004;124:1446-57.
79. Berger MM, Chiolero RL. Hypocaloric feeding: pros and cons. Curr Opin Crit Care 2007;13:180-6.
80. Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-6.
81. Milbrandt EB, Kersten A, Kong L, Weissfeld LA, Clermont G, Fink MP et al. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005;33:226-9.
82. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-9.